Changes and significance of serum sMICA levels in patients with recurrent miscarriage before and after lymphocyte infusion therapy

J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):267-270. doi: 10.23812/20-635-L.

Authors

L P Wang¹, G L Luo², J Liu³, J X Xu¹, K Liu¹, F T Sun¹, Q L Zhou¹

Affiliations

¹ Department of Blood Transfusion, Weifang People's Hospital, Weifang, Shandong Province, China.
² Department of Obstetrics and Gynecology, Jiyang People's Hospital, Jinan, Shandong Province, China.
³ Health Management Department, Jiyang People's Hospital, Jinan, Shandong Province, China.

PMID: 33509340
DOI: 10.23812/20-635-L

No abstract available

Keywords: lymphocyte infusion therapy; recurrent spontaneous abortion; sMICA.

Publication types

Letter

MeSH terms

Abortion, Habitual* / therapy
Female
Histocompatibility Antigens Class I
Humans
Lymphocytes
Pregnancy

Substances

Histocompatibility Antigens Class I